287 related articles for article (PubMed ID: 33443835)
1. [Newborn screening for severe T and B lymphocyte deficiencies in Switzerland].
Fouriki A; Schnider C; Theodoropoulou K; Pachlopnik J; Hofer M; Candotti F
Rev Med Suisse; 2021 Jan; 17(720-1):68-76. PubMed ID: 33443835
[TBL] [Abstract][Full Text] [Related]
2. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
Front Immunol; 2020; 11():1948. PubMed ID: 33178177
[TBL] [Abstract][Full Text] [Related]
3. Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study.
Somech R; Lev A; Simon AJ; Korn D; Garty BZ; Amariglio N; Rechavi G; Almashanu S; Zlotogora J; Etzioni A
Isr Med Assoc J; 2013 Aug; 15(8):404-9. PubMed ID: 24079059
[TBL] [Abstract][Full Text] [Related]
4. Swiss newborn screening for severe T and B cell deficiency with a combined TREC/KREC assay - management recommendations.
Trück J; Prader S; Natalucci G; Hagmann C; Brotschi B; Kelly J; Bassler D; Steindl K; Rauch A; Baumgartner M; Fingerhut R; Hauri-Hohl M; Güngör T; Pachlopnik Schmid J; Berger C; Reichenbach J
Swiss Med Wkly; 2020 Jun; 150():w20254. PubMed ID: 32579701
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of TREC based newborn screening results and clinical phenotypes in infants with the 22q11 deletion syndrome.
Lingman Framme J; Borte S; von Döbeln U; Hammarström L; Oskarsdóttir S
J Clin Immunol; 2014 May; 34(4):514-9. PubMed ID: 24610337
[TBL] [Abstract][Full Text] [Related]
6. Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls.
Şentürk G; Ng YY; Eltan SB; Başer D; Ogulur I; Altındirek D; Fırtına S; Yılmaz H; Kocamış B; Kıykım A; Camcıoğlu Y; Ar MC; Sudutan T; Beken S; Temel ŞG; Alanay Y; Karakoc-Aydiner E; Barış S; Özen A; Özbek U; Sayitoğlu M; Hatırnaz Ng Ö
Scand J Immunol; 2022 Mar; 95(3):e13130. PubMed ID: 34951041
[TBL] [Abstract][Full Text] [Related]
7. Newborn Screening through TREC, TREC/KREC System for Primary Immunodeficiency with limitation of TREC/KREC. Comprehensive Review.
Shinwari K; Bolkov M; Tuzankina IA; Chereshnev VA
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(2):132-149. PubMed ID: 32748762
[TBL] [Abstract][Full Text] [Related]
8. Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns.
Marakhonov AV; Efimova IY; Mukhina AA; Zinchenko RA; Balinova NV; Rodina Y; Pershin D; Ryzhkova OP; Orlova AA; Zabnenkova VV; Cherevatova TB; Beskorovainaya TS; Shchagina OA; Polyakov AV; Markova ZG; Minzhenkova ME; Shilova NV; Larin SS; Khadzhieva MB; Dudina ES; Kalinina EV; Mudaeva DA; Saydaeva DH; Matulevich SA; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Nurgalieva LR; Saifullina EV; Belyaeva TI; Romanova OS; Voronin SV; Shcherbina A; Kutsev SI
J Clin Immunol; 2024 Apr; 44(4):93. PubMed ID: 38578360
[TBL] [Abstract][Full Text] [Related]
9. When Screening for Severe Combined Immunodeficiency (SCID) with T Cell Receptor Excision Circles Is Not SCID: a Case-Based Review.
Buchbinder D; Walter JE; Butte MJ; Chan WY; Chitty Lopez M; Dimitriades VR; Dorsey MJ; Nugent DJ; Puck JM; Singh J; Collins CA
J Clin Immunol; 2021 Feb; 41(2):294-302. PubMed ID: 33411155
[TBL] [Abstract][Full Text] [Related]
10. Newborn screening for severe combined immunodeficiency using a novel and simplified method to measure T-cell excision circles (TREC).
Tagliaferri L; Kunz JB; Happich M; Esposito S; Bruckner T; Hübschmann D; Okun JG; Hoffmann GF; Schulz A; Kappe J; Speckmann C; Muckenthaler MU; Kulozik AE
Clin Immunol; 2017 Feb; 175():51-55. PubMed ID: 27916705
[TBL] [Abstract][Full Text] [Related]
11. Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study.
Barbaro M; Ohlsson A; Borte S; Jonsson S; Zetterström RH; King J; Winiarski J; von Döbeln U; Hammarström L
J Clin Immunol; 2017 Jan; 37(1):51-60. PubMed ID: 27873105
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates.
Boyarchuk O; Yarema N; Kravets V; Shulhai O; Shymanska I; Chornomydz I; Hariyan T; Volianska L; Kinash M; Makukh H
Front Immunol; 2022; 13():999664. PubMed ID: 36189201
[TBL] [Abstract][Full Text] [Related]
13. TREC/KREC Newborn Screening followed by Next-Generation Sequencing for Severe Combined Immunodeficiency in Japan.
Wakamatsu M; Kojima D; Muramatsu H; Okuno Y; Kataoka S; Nakamura F; Sakai Y; Tsuge I; Ito T; Ueda K; Saito A; Morihana E; Ito Y; Ohashi N; Tanaka M; Tanaka T; Kojima S; Nakajima Y; Ito T; Takahashi Y
J Clin Immunol; 2022 Nov; 42(8):1696-1707. PubMed ID: 35902420
[TBL] [Abstract][Full Text] [Related]
14. Ataxia Telangiectasia Diagnosed on Newborn Screening-Case Cohort of 5 Years' Experience.
Mandola AB; Reid B; Sirror R; Brager R; Dent P; Chakroborty P; Bulman DE; Roifman CM
Front Immunol; 2019; 10():2940. PubMed ID: 31921190
[TBL] [Abstract][Full Text] [Related]
15. [A first pilot study on the neonatal screening of primary immunodeficiencies in Spain: TRECS and KRECS identify severe T- and B-cell lymphopenia].
Olbrich P; de Felipe B; Delgado-Pecellin C; Rodero R; Rojas P; Aguayo J; Marquez J; Casanovas J; Sánchez B; Lucena JM; Ybot-Gonzalez P; Borte S; Neth O
An Pediatr (Barc); 2014 Nov; 81(5):310-7. PubMed ID: 25278007
[TBL] [Abstract][Full Text] [Related]
16. The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives…one at a time.
Quinn J; Orange JS; Modell V; Modell F
Immunol Res; 2020 Feb; 68(1):48-53. PubMed ID: 32128663
[TBL] [Abstract][Full Text] [Related]
17. TREC and KREC profiling as a representative of thymus and bone marrow output in patients with various inborn errors of immunity.
Dasouki M; Jabr A; AlDakheel G; Elbadaoui F; Alazami AM; Al-Saud B; Arnaout R; Aldhekri H; Alotaibi I; Al-Mousa H; Hawwari A
Clin Exp Immunol; 2020 Oct; 202(1):60-71. PubMed ID: 32691468
[TBL] [Abstract][Full Text] [Related]
18. Newborn Screening for Primary Immunodeficiency Diseases: History, Current and Future Practice.
King JR; Hammarström L
J Clin Immunol; 2018 Jan; 38(1):56-66. PubMed ID: 29116556
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for severe combined immunodeficiency: Evaluation of a commercial T-cell receptor excision circle-based method in Victorian dried blood spots.
Richards S; Pitt J; Choo S
J Paediatr Child Health; 2018 Jan; 54(1):14-19. PubMed ID: 28861919
[TBL] [Abstract][Full Text] [Related]
20. Establishing Simultaneous T Cell Receptor Excision Circles (TREC) and K-Deleting Recombination Excision Circles (KREC) Quantification Assays and Laboratory Reference Intervals in Healthy Individuals of Different Age Groups in Hong Kong.
Kwok JSY; Cheung SKF; Ho JCY; Tang IWH; Chu PWK; Leung EYS; Lee PPW; Cheuk DKL; Lee V; Ip P; Lau YL
Front Immunol; 2020; 11():1411. PubMed ID: 32765500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]